Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Am J Surg Pathol. 2020 Oct;44(10):1406–1412. doi: 10.1097/PAS.0000000000001533

Table 1.

Clinical and pathologic features of tumors arising in ASH and NASH (Mount Sinai cohort)

ASH NASH
Age, year, mean (SD) 58 (7.2) 69 (5.1) p<0.0001
M:F 18:1 16:8 p=0.055
# tumors 3.1 (SD 1.9) 2.5 (SD 2.0) p=0.36
Tumor size, cm mean (SD) 1.7 (SD 1.0) 2.0 (SD 1.5) p=0.13
Tumor differentiation (per tumor nodule) p=0.12
Well 12 (27%) 8 (16%)
Moderate 31 (70%) 35 (71%)
Poor 1 (3%) 6 (12%)
Microscopic vascular invasion 10/19 (53%) 16/24 (67%) p=0.53
Macroscopic vascular invasion 1/19 (5%) 1/24 (4%) p=1
AFP > 9 10/18 (56%) 9/22 (41%) p=0.53
SH-HCC 14/19 (74%) 17/24 (71%) p=1
Predominant SH-HCC 9/19 (47%) 12/24 (50%) p=1
Glycogenated hepatocyte nuclei 7/19 (37%) 15/24 (63%) p=0.13